Slomka M J
Virus Reference Division, PHLS Central Public Health Laboratory, London, England.
Commun Dis Rep CDR Rev. 1996 Mar 1;6(3):R41-5.
Herpes simplex virus (HSV) type 2 is the main cause of genital herpes infections. Conventional serological techniques cannot discriminate between antibodies specific to HSV types 1 and 2, so these methods cannot be used in the seroepidemiological investigation of genital herpes infections. The discovery of type specific antigens in HSV-1 and HSV-2, most notably glycoprotein G (gG), has been successfully exploited to develop assays for the detection of type specific HSV antibody. The presence of type specific antibodies provides evidence for infection with HSV-1, HSV-2, or both. Tests which detect humoral responses to HSV-2 have been used during the past decade to investigate populations in various countries. Most surveys of general adult populations in the developed world have found a relatively low seroprevalence of HSV-2, although this does differ between countries. Studies of HSV-2 antibody in developing countries have revealed higher rates of infection in adults. People attending sexually transmitted diseases (STD) clinics have higher rates of HSV-2 infection than general populations sampled in the same country. Assays of HSV type specific antibodies have been used in seroepidemiological surveys that include information about demography and sexual behaviour to identify risk factors for HSV-2 infection. The surveys show that people with a large number of sexual partners are at increased risk of acquiring HSV-2 infection and that a high proportion of HSV-2 infections are asymptomatic. Assays of HSV type specific antibody have been used to show that the presence of pre-existing HSV-1 antibody may reduce the severity of genital HSV-2 infection. Such assays have also been used in studies of the transmission of genital herpes. Proposed interventions to counter the spread of genital herpes include targeted education and vaccination programmes. Assays of HSV type specific antibodies may be used to monitor the effectiveness of such policies.
2型单纯疱疹病毒(HSV)是生殖器疱疹感染的主要病因。传统血清学技术无法区分针对1型和2型HSV的特异性抗体,因此这些方法不能用于生殖器疱疹感染的血清流行病学调查。HSV-1和HSV-2中型特异性抗原的发现,最显著的是糖蛋白G(gG),已成功用于开发检测型特异性HSV抗体的检测方法。型特异性抗体的存在为HSV-1、HSV-2或两者感染提供了证据。在过去十年中,检测对HSV-2体液反应的检测方法已被用于调查各国人群。发达国家对一般成年人群的大多数调查发现HSV-2的血清流行率相对较低,尽管各国之间存在差异。发展中国家对HSV-2抗体的研究显示成年人感染率较高。就诊于性传播疾病(STD)诊所的人群比在同一国家抽样的一般人群有更高的HSV-2感染率。HSV型特异性抗体检测已用于血清流行病学调查,这些调查包括有关人口统计学和性行为的信息,以确定HSV-2感染的危险因素。调查表明,有大量性伴侣的人感染HSV-2的风险增加,并且高比例的HSV-2感染是无症状的。HSV型特异性抗体检测已被用于表明预先存在的HSV-1抗体的存在可能会降低生殖器HSV-2感染的严重程度。此类检测也已用于生殖器疱疹传播的研究。为应对生殖器疱疹传播而提出的干预措施包括有针对性的教育和疫苗接种计划。HSV型特异性抗体检测可用于监测此类政策的有效性。